96TH GENERAL ASSEMBLY
State of Illinois
2009 and 2010
HB0185

 

Introduced 1/14/2009, by Rep. Patricia R. Bellock

 

SYNOPSIS AS INTRODUCED:
 
New Act

    Creates the MRSA Screening, Prevention, and Reporting Act for State Residential Facilities. Requires State residential facilities to establish an MRSA control program. Defines "State residential facility" to mean: (i) Department of Human Services operated residential facilities, including State mental health hospitals and other facilities; (ii) Department of Corrections operated correctional centers, work camps or boot camps, and adult transition centers; and (iii) Department of Juvenile Justice operated juvenile centers and boot camps. Sets forth required features of the MRSA control program, including screening and surveillance, reporting, prevention, infection control, and treatment. Includes requirements for training of employees and others. Effective immediately.


LRB096 03355 DRJ 14443 b

FISCAL NOTE ACT MAY APPLY

 

 

A BILL FOR

 

HB0185 LRB096 03355 DRJ 14443 b

1     AN ACT concerning health.
 
2     Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
 
4     Section 1. Short title. This Act may be cited as the MRSA
5 Screening, Prevention, and Reporting Act for State Residential
6 Facilities.
 
7     Section 5. Definition. In this Act, "State residential
8 facility" or "facility" means: any Department of Human Services
9 operated residential facility, including any State mental
10 health hospital, State developmental center, or State
11 residential school for the deaf and visually impaired; any
12 Department of Corrections operated correctional center, work
13 camp or boot camp, or adult transition center; and any
14 Department of Juvenile Justice operated juvenile center or boot
15 camp.
 
16     Section 10. MRSA control procedures. In order to improve
17 the prevention of infections due to methicillin-resistant
18 Staphylococcus aureus ("MRSA"), every State residential
19 facility shall establish MRSA control procedures that include
20 the following features:
21         (1) Screening and surveillance. Upon admission or
22     incarceration, all individuals shall be screened for MRSA

 

 

HB0185 - 2 - LRB096 03355 DRJ 14443 b

1     infection and colonization.
2         (2) Reporting.
3             (A) All confirmed MRSA and other
4         antibiotic-resistant infections shall be documented in
5         the resident, patient, student, or inmate's medical
6         record.
7             (B) All confirmed MRSA and other
8         antibiotic-resistant infections shall be reported to
9         the director of the department operating the facility
10         and to the Department of Public Health. The report
11         shall indicate whether the MRSA infection was present
12         on intake or contracted at the facility, if known.
13         (3) Prevention.
14             (A) Education. Employees, residents, patients,
15         students, and inmates of the facility shall be provided
16         with information on the transmission, prevention,
17         treatment, and containment of MRSA infections.
18             (B) Hand Hygiene procedures: Each facility shall
19         develop and implement hand hygiene procedures for
20         employees, residents, patients, students, and inmates
21         of the facility that includes adequate hand-washing
22         equipment and supplies and regular training on
23         effective hand hygiene techniques and education on the
24         importance of hand hygiene. These trainings must be
25         conducted at least twice each year and may be conducted
26         in conjunction with other trainings.

 

 

HB0185 - 3 - LRB096 03355 DRJ 14443 b

1             (C) Sanitation. Each facility shall develop and
2         implement sanitation procedures for cleaning and
3         disinfecting the environment that includes the
4         following:
5                 (i) Use of an Environmental Protection Agency
6             (EPA)-registered disinfectant according to the
7             manufacturer's instructions.
8                 (ii) Regularly cleaning or disinfecting
9             washable surfaces in residents', patients', and
10             students' rooms, in inmates' cells, and in shared
11             areas such as showers, fitness areas, and food
12             services areas.
13                 (iii) Cleaning or disinfecting restraining
14             devices after every use.
15                 (iv) Treating all linen (towels, sheets, and
16             similar items) as potentially infectious and
17             following recommendations of the Centers for
18             Disease Control and Prevention for laundering.
19             (D) Personal protective equipment. Employees of
20         the facility shall be provided with personal
21         protective equipment (gloves, eye protection, and
22         gowns) for use when contact with blood, body fluids, or
23         wound drainage is likely.
24             (E) Isolation of residents, patients, students, or
25         inmates with MRSA. Each State residential facility
26         shall develop guidelines for isolating or cohorting

 

 

HB0185 - 4 - LRB096 03355 DRJ 14443 b

1         MRSA-diagnosed residents, patients, students, or
2         inmates from others when a clinician determines the
3         individual to be a high risk for spreading the
4         contagion. Residents, patients, students, or inmates
5         diagnosed with MRSA shall be examined by a clinician to
6         determine their risk of contagion to others. The
7         determination about whether to isolate residents,
8         patients, students, or inmates with MRSA infections
9         shall include consideration of the degree to which
10         wound drainage can be contained and the ability or
11         willingness of a resident, patient, student, or inmate
12         to comply with infection control instructions.
13         (4) Infection control. Upon the diagnosis of a single
14     MRSA case at a State residential facility, that facility
15     shall implement surveillance measures to detect additional
16     MRSA cases through the following procedures:
17             (A) The individual diagnosed with MRSA shall be
18         interviewed to identify potential sources of
19         infections and close contacts. The interview should
20         seek to determine the date of onset and activity
21         immediately before and following onset, including
22         recent hospitalizations, housing, work assignments,
23         sharing of personal hygiene items, sexual contact,
24         participation in close-contact sports, or exposure to
25         other residents, patients, students, or inmates with
26         draining wounds or skin infections.

 

 

HB0185 - 5 - LRB096 03355 DRJ 14443 b

1             (B) Employees, residents, patients, students, or
2         inmates of the facility identified as having contact
3         with the infected individual should be examined for
4         signs and symptoms of infection and screened for
5         colonization.
6             (C) State residential facility management shall
7         inform all employees of the facility that an occurrence
8         of MRSA infection has been identified. The
9         notification must protect the identity and
10         confidential information of the infected individual.
11         Management shall immediately conduct training on MRSA
12         and hand hygiene, in addition to the training required
13         under subdivision (3)(B) of this Section, unless there
14         has been a confirmed case of MRSA at the facility
15         within the previous 6 months and a training was
16         conducted at that time.
17             (D) State residential facility management shall
18         inform all health care providers evaluating residents
19         or inmates of the facility of the MRSA infection
20         occurrence so they may be on the alert for inmates with
21         skin or soft tissue infections or other evidence of
22         MRSA infections.
23             (E) No resident, patient, student, or inmate with a
24         skin or soft tissue infection shall be transferred to
25         another facility until fully evaluated and
26         appropriately treated as described in this

 

 

HB0185 - 6 - LRB096 03355 DRJ 14443 b

1         subparagraph (E), except when required for security
2         reasons, medical care, or other special circumstances.
3         Residents, patients, students, or inmates with MRSA
4         infections requiring transfer shall have draining
5         wounds dressed the day of transfer to contain the
6         draining. Escort personnel shall be notified of the
7         resident, patient, student, or inmate's condition and
8         educated on infection control measures. The clinical
9         director of the sending facility or his or her designee
10         shall notify the receiving institution's clinical
11         director or health services administrator of pending
12         transfers of individuals with MRSA. This subparagraph
13         (E) does not apply to discharges and is not intended to
14         limit the individual's right to leave an institutional
15         setting.
16         (5) Treatment. The Department of Public Health shall
17     develop a MRSA treatment protocol for each department
18     operating a State residential facility. Upon issuance of
19     the protocol by the Department of Public Health, each
20     department operating a State residential facility shall
21     educate all clinical staff at the facility and healthcare
22     vendors for the facility on that protocol.
 
23     Section 99. Effective date. This Act takes effect upon
24 becoming law.